Portrait of Natalia Zorrilla
  • Telehealth visits
bch logo

Natalia Zorrilla, NP

Neurology (Headache Medicine)
Pediatric Headache Mission Bay
877-822-4453
Portrait of Natalia Zorrilla
Portrait of Natalia Zorrilla
bch logo

Natalia Zorrilla, NP

Neurology (Headache Medicine)
Pediatric Headache Mission Bay
877-822-4453

On this page

About me

Natalia Zorrilla is a nurse practitioner who cares for children and adolescents with complex neurological conditions, focusing particularly on pediatric headache disorders. She collaborates closely with teams across many specialties to personalize and optimize treatment plans and to oversee patients having infusion therapies. In addition, she leads a clinic that supports patients and families during the move from pediatric to adult care, making sure they feel confident about managing their health during the transition. Professionally, she is interested in using the latest research to address chronic headaches as well as in promoting young patients' self-management skills to improve their long-term health outcomes.

Zorrilla earned her master's degree in nursing at UCSF.

In response to the lack of research on children and teens living with frequent headaches, Zorrilla works on developing new migraine treatments for this group. Her goal is to contribute to studies that find ways for young people with headache disorders to feel better and live as fully as possible.

Education & training

Board certification

  • Pediatric Primary Care Nurse Practitioner, Pediatric Nursing Certification Board (PNCB)

Degree

  • MSN, UCSF School of Nursing

My expertise

Locations

    Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.

    For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.

    The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.